Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for Peripheral Arterial Disease
32 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07223593·Phase 3·Recruiting·Listed Nov 2025
Clinical research site in Waco, Texas
Part of NextStage Clinical Research
As of July 2026, 2 paid clinical trials are recruiting at Nextstage Clinical Research - Waco in Waco, Texas. Active studies at this site focus on Peripheral Arterial Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .